Oseltamivir
Product Description
Swiftmed International Private Limited
-
Country/Region:India
-
On CPHI since:2026
-
Certificates:3
-
Employees:100 - 249
Company types
Primary activities
Categories
Specifications
Swiftmed International Private Limited
-
Country/Region:India
-
On CPHI since:2026
-
Certificates:3
-
Employees:100 - 249
Company types
Primary activities
More Products from Swiftmed International Private Limited (90)
-
Product Meropenem Trihydrate
Injectable vials are manufactured in 250 mg, 500 mg, and 1 g (1000 mg) strengths to accommodate precise dosing across pediatric, adult, and renally impaired patient populations. Because it is an ultra-broad-spectrum carbapenem antibiotic that treats severe, life-threatening infections, matching the appropr... -
Product Micafungin Injection
Micafungin for Injection (50 mg and 100 mg strengths) is a prescription-strength, intravenous echinocandin antifungal agent formulated to treat severe, systemic fungal infections. Instead of traditional liquid formats, it is supplied as a sterile, preservative-free lyophilized (freeze-dried) powder cake in... -
Product Mirabegron
Mirabegron Extended-Release (ER) Tablets (25 mg and 50 mg strengths) are high-potency oral medications prescribed for the symptomatic management of urological storage disorders. Representing a significant therapeutic shift from traditional anticholinergic drugs, mirabegron functions as a highly selective a... -
Product Nifedipine Extended Release
Nifedipine Extended-Release (ER) is a prescription oral cardiovascular medication used to manage chronic high blood pressure (hypertension) and prevent chronic stable angina (chest pain). It belongs to the class of medications known as dihydropyridine calcium channel blockers. -
Product Octreotide Acetate Injection
Octreotide Acetate Injection (100 mcg/mL) is a high-potency, synthetic polypeptide medication prescribed to manage severe endocrine disorders, specific gastrointestinal hemorrhages, and neuroendocrine tumors. Functioning as a long-acting analogue of natural somatostatin, it provides a more stable and prolo... -
Product Orforglipron Tablet
Orforglipron Tablet is an oral, small-molecule, non-peptide Glucagon-Like Peptide-1 (GLP-1) receptor agonist designed for daily administration. It is developed to support chronic weight management and improve glycemic control in patients with metabolic conditions. Other Peptides: Tirzepatide Semag... -
Product Paliperidone
Paliperidone Extended-Release (ER) Tablets (available in 1.5 mg, 3 mg, 6 mg, 9 mg, and 12 mg strengths) are high-potency, second-generation (atypical) oral antipsychotic medications. They are prescribed for the acute and maintenance management of psychiatric conditions by stabilizing dopamine and serotonin... -
Product Pioglitazone + Metformin
Pioglitazone combined with metformin hydrochloride extended-release (XR) is a prescription fixed-dose oral antidiabetic medication used to improve blood sugar control in adults with type 2 diabetes. It pairs a thiazolidinedione (TZD) with a biguanide to target severe insulin resistance in muscle, fat, and ... -
Product Prasugrel
Prasugrel is a prescription oral antiplatelet medication used to prevent blood clots in patients with acute coronary syndrome who are undergoing a procedure to open blocked heart arteries. It belongs to the thienopyridine class of medications and functions as a highly potent inhibitor of platelet aggregation. -
Product Ranolazine
Ranolazine Sustained-Release (SR) is a prescription oral cardiovascular medication used as a chronic maintenance therapy to treat chronic stable angina (chest pain). It belongs to a unique class of antianginal medications that reduces chest pain without significantly changing heart rate or blood pressure -
Product Research Peptides
Our peptide portfolio includes custom and catalog peptides manufactured with a focus on quality, purity, and analytical characterization. Products are supplied with appropriate documentation to support laboratory research and development activities, including peptide discovery, assay development, and precl... -
Product Rifampicin + Isoniazid
Rifampicin + Isoniazid Tablets 150 mg/150 mg are a fixed-dose combination (FDC) antitubercular medicine containing two first-line anti-tuberculosis agents: Rifampicin 150 mg and Isoniazid 150 mg. The combination is formulated to provide effective bactericidal activity against Mycobacterium tuberculosis whi...











